Clinical Trial Update: Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating chemoradiotherapy with or without atezolizumab for localized muscle-invasive bladder cancer; the study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer
• Stage Iiia Bladder Cancer
• Urothelial Carcinoma of the Bladder

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING